Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy

Detalles Bibliográficos
Autores principales: Moss, Leslie Anne, Keith, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643292/
http://dx.doi.org/10.1186/1939-4551-6-S1-P205
_version_ 1782268295053836288
author Moss, Leslie Anne
Keith, Paul
author_facet Moss, Leslie Anne
Keith, Paul
author_sort Moss, Leslie Anne
collection PubMed
description
format Online
Article
Text
id pubmed-3643292
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36432922013-05-08 Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy Moss, Leslie Anne Keith, Paul World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643292/ http://dx.doi.org/10.1186/1939-4551-6-S1-P205 Text en Copyright ©2013 Moss and Keith; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Moss, Leslie Anne
Keith, Paul
Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
title Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
title_full Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
title_fullStr Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
title_full_unstemmed Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
title_short Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
title_sort basic and clinical immunology – 3030. subcutaneous immunoglobulin therapy: an option for patients who have experienced thrombotic complications with intravenous therapy
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643292/
http://dx.doi.org/10.1186/1939-4551-6-S1-P205
work_keys_str_mv AT mossleslieanne basicandclinicalimmunology3030subcutaneousimmunoglobulintherapyanoptionforpatientswhohaveexperiencedthromboticcomplicationswithintravenoustherapy
AT keithpaul basicandclinicalimmunology3030subcutaneousimmunoglobulintherapyanoptionforpatientswhohaveexperiencedthromboticcomplicationswithintravenoustherapy

Ejemplares similares